Andrew Chalmers

Dr. Chalmers is the CEO of CiteAb and a visiting Lecturer at the University of Bath. He conceived the idea of a citation-based antibody search engine, co-founded CiteAb, and now leads the company in its mission to help scientists and suppliers by collecting reagent citation data.

He has a long-standing interest in antibody validation and is a scientific organiser of the International Antibody Validation Meeting series.

Dr. Chalmers’ research background is in cell biology and prior to moving to a full-time position at CiteAb his research group focused on understanding the development and proliferation of epithelial cells.